• How The New European Health Data Space Will Drive The Development Of AI-Based Tools

    Sep 12 | Bio-IT World | The European Health Data Space (EHDS) is an exciting new initiative that aims to advance digital health for all European Union (EU) Member States—the largest European healthcare initiative in history. EHDS has two distinct goals: facilitating the movement of health data across borders for healthcare purposes (EHDS1) and utilizing healthcare data for scientific research and innovation (EHDS2). More

  • Illumina’s Commercial Launch of Proteomics Assay, Acquisiton of SomaLogic

    Sep 10 | Bio-IT World | At the J.P. Morgan Healthcare Conference in January, sequencing company after sequencing company laid out their vision for 2025: the year of the proteome. Illumina joined the chorus. Jacob Thaysen, Illumina’s CEO, highlighted proteomics as a particularly exciting area of focus. More

  • First-in-Class Dietary Supplement a Potentially Big Win for Babies

    Sep 09 | Bio-IT World | Modern medical practices like antibiotics and C-sections, coupled with an industrialized food system that prioritizes high yields and profitability over nutritional quality, have left most babies born today lacking the gut microbes they need before kindergarten to train their immune system for life. The deficiency in these types of Bifidobacterium affects all but a fraction of infants in the United States, putting them at risk for developing atopic disease conditions that include food allergies, eczema, and asthma. More

  • Microbiome-Based Therapies Hold Promise for Chronic Diseases

    Sep 04 | Bio-IT World| Researchers in Denmark report finding a potential new route for developing microbiome-based therapies by providing “a concrete example” of how specific bacterial proteins might be used in the treatment of chronic metabolic diseases. Specifically, they identified a common gut bacterium capable of producing hormone-like proteins measurably influencing weight, bone density, and blood sugar regulation in preclinical models. More

  • Psilocybin Being Investigated as an Anti-Aging Agent

    Sep 03 | Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases. More

  • Machine Learning Penetrance Score Predicts Genetic Variant Impacts

    Sep 02 | Bio-IT World | Researchers at the Icahn School of Medicine at Mount Sinai have published a machine learning model to predict penetrance of genetic variants—how likely the variants are to cause disease. The tool combines genomic and clinical phenotype data to evaluate penetrance at scale, offering refined, individualized disease risk estimates. The study was published last week in Science (DOI: 10.1126/science.adm7066). More

  • Ultima’s ppmSeq Pushes Sequencing to New Levels of Accuracy

    Aug 28 | Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays. More

  • Follow the Money: Rheumatoid Arthritis Therapy, Novel Next-Gen Biosensor, More

    Aug 27 | Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more. More

  • BioMed X, Novo Nordisk Collaboration, 10x Genomics Launches Platform Addition, More

    Aug 26 | Bio-IT World| BioMed X announced the launch of a new collaboration with Novo Nordisk; 10x Genomics launched Xenium Protein, a new addition to its Xenium Spatial platform; and more. More

  • Bioprocessing Summit Honors LISURE as Best of Show Winner

    Aug 21 | Bio-IT World | During this week’s Bioprocessing Summit in Boston, M++ UltraPilot from LISURE was named the winner of the Best of Show People’s Choice Award competition. Other finalists and their products were also named and featured. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!